therapeutic drug monitoring

Therapeutic drug monitoring (TDM) is the practice of measuring the actual concentration of a drug in a patient's blood and using that number to fine-tune the dose. Instead of guessing from the label dose, the clinician checks where the patient really sits and adjusts — like using a thermostat reading to set the heating rather than just turning the dial blindly.

TDM is reserved for drugs where it genuinely helps: those with a narrow therapeutic window (the gap between effective and toxic is small), wide and unpredictable variation between patients, a measurable concentration that correlates with effect or toxicity, and no easier clinical marker of response. Sampling timing matters — trough levels (just before the next dose) and sometimes peak levels are interpreted against established target ranges.

Done well, TDM individualises therapy, catches accumulation early, confirms adherence, and guides dosing in special populations such as renal failure. Its limits are real: the number reflects total plasma drug, but only the unbound free fraction is active, so altered protein binding can mislead. TDM informs judgment; it does not replace looking at the patient.